Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 6 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-10-01 4 AS $27.00 $185,085 I/I (6,855) 3,281,564     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-30 4 AS $27.00 $61,884 I/I (2,292) 3,288,419     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-30 4 AS $27.00 $103,572 I/I (3,836) 5,393,967     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-30 4 AS $27.00 $61,884 I/I (2,292) 3,288,419     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-28 4 AS $27.00 $518,778 I/I (19,214) 3,290,711     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-28 4 AS $27.00 $868,158 I/I (32,154) 5,397,803     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-28 4 AS $27.00 $518,778 I/I (19,214) 3,290,711     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-27 4 AS $27.09 $314,921 I/I (11,625) 3,309,925     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-27 4 AS $27.09 $314,921 I/I (11,625) 3,309,925     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-27 4 AS $27.09 $527,036 I/I (19,455) 5,429,957     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-24 4 AS $27.81 $136,631 I/I (4,913) 3,321,550     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-24 4 AS $27.81 $136,631 I/I (4,913) 3,321,550     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-09-24 4 AS $28.02 $30,512 D/D (1,089) 99,026     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-24 4 AS $27.81 $228,626 I/I (8,221) 5,449,412     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-23 4 AS $27.96 $1,032,864 I/I (36,930) 3,326,463     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-23 4 AS $27.96 $1,032,864 I/I (36,930) 3,326,463     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-09-23 4 AS $28.16 $149,862 D/D (5,322) 100,115     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-23 4 AS $27.96 $1,728,432 I/I (61,800) 5,457,633     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-22 4 AS $27.54 $393,657 I/I (14,294) 3,363,393     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-22 4 AS $27.54 $393,657 I/I (14,294) 3,363,393     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-22 4 AS $27.54 $658,784 I/I (23,921) 5,519,433     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-21 4 AS $27.47 $539,373 I/I (19,635) 3,377,687     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-21 4 AS $27.47 $539,373 I/I (19,635) 3,377,687     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-21 4 AS $27.47 $902,609 I/I (32,858) 5,543,354     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-20 4 AS $27.03 $668,008 I/I (24,303) 3,397,322     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us